Farmasian laitos - Tapahtuma-arkisto

Pharmaceutical Policy Webinar

De novo cholesterol biosynthesis as a metabolic vulnerability in rhabdomyosarcoma – implications for novel treatment options

Unusual suspects in pathology of CAD and Cancer-Related Cardiovascular Risk - Microcirculation Matters

Housing, Environment and Health Outcomes in the United States

Shaping the future of high-risk myelodysplastic syndromes with bexmarilimab